| 384.5 | N02CX01 | pizotifen | p.o. | 1.5 | MG | 6,00 | |||
| 384.6 | N02CC01 | sumatriptan | parent. | 1 | DF | 850,00 | X | ||
| 385 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 385.1 | N03AA | fenobarbital pseudonorefedr. | p.o. | 0.1 | GM | 2,10 | |||
| 385.2 | N03AA02 | fenobarbital (do 15 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 6,45 | |||
| 68578 | PHENAEMALETTEN | tbl 50×15mg | DET | D | |||||
| 385.3 | N03AA02 | fenobarbital (nad 15 mg v jedné tabletě) | p.o. | 0.1 | GM | 2,45 | |||
| 68579 | PHENAEMAL 0.1 | tbl 50×100mg | DET | D | |||||
| 385.4 | N03AA03 | primidon (pevné lékové formy) | p.o. | 1.25 | GM | 5,00 | |||
| 86621 | MYSOLINE | tbl 100×250mg | ZNC | GB | |||||
| 385.5 | N03AA03 | primidon (tekuté lékové formy) | p.o. | 1.25 | GM | 46,55 | |||
| 66562 83437 | LISKANTIN LISKANTIN | sus 1×150ml/3.75gm sus 1×250ml/6.25gm | DET DET | D D | |||||
| 386 | N03AA | antiepileptika ze skupiny barbiturátů a jejich derivátů | parent. | O | |||||
| 386.1 | N03AA02 | fenobarbital (do 40 mg včetně v jedné ampuli) | parent. | 0.1 | GM | 135,25 | O | ||
| 66845 | GARDENAL | inj sic 1×40mg+solv | SPC | F | |||||
| 386.2 | N03AA02 | fenobarbital (nad 40 mg v jedné ampuli) | parent. | 0.1 | GM | 14,30 | O | ||
| 84449 | LUMINAL | inj 5×1ml/219mg | DET | D | |||||
| 387 | N03AB | antiepileptika ze skupiny hydantoinů | p.o. | ||||||
| 387.1 | N03AB02 | fenytoin | p.o. | 0.3 | GM | 2,50 | |||
| 62234 00297 | EPILAN D GEROT SODANTON | tbl 100×100mg tbl 20×100mg | GER SLO | A SK | |||||
| 387.2 | N03AB04 | mefenytoin | p.o. | 0.4 | GM | 2,50 | |||
| 387.3 | N03AB52 | fenytoin, kombinace | p.o. | 3 | DF | 2,05 | |||
| 00291 | SANEPIL | tbl 20 | SLO | SK | |||||
| 388 | N03AB | antiepileptika ze skupiny hydantoinů | parent. | O | |||||
| 388.1 | N03AB02 | fenytoin | parent. | 0.3 | GM | 125,05 | O | ||
| 03300 66564 | EPANUTIN PHENHYDAN | inj 5×5ml/250mg inj 5×5ml/250mg | PDA DET | GB D | |||||
| 389 | N03AD | antiepileptika ze skupiny sukcinimidů | p.o. | ||||||
| 389.1 | N03AD01 | ethosuximid (pevné lékové formy) | p.o. | 1.25 | GM | 17,45 | |||
| 93710 | SUXILEP | cps 120×250mg | VJP | D | |||||
| 389.2 | N03AD01 | ethosuximid (tekuté lékové formy) | p.o. | 1.25 | GM | 23,60 | ||||
| 68585 02035 | PETNIDAN SUXILEP | sir 1×150ml/7.5gm gtt 50gm 50% | DET GMD | D D | ||||||
| 389.3 | N03AD03 | mesuximid | p.o. | 0.9 | GM | 25,35 | ||||
| 97311 92066 | PETINUTIN 300 PETINUTIN 300 | cps 100×300mg cps 100×300mg | GOD PDA | D D | ||||||
| 390 | N03AE | antiepileptika ze skupiny benzodiazepinů | p.o. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 390.1 | N03AE01 | klonazepam (tekuté lékové formy) | p.o. | 8 | MG | 34,95 | ||||
| 03029 | RIVOTRIL | gtt 10ml 25mg | HLR | CH | ||||||
| 390.2 | N03AE01 | klonazepam (pevné lékové formy do 0,5 mg v jedné tabletě včetně) | p.o. | 8 | MG | 24,70 | ||||
| 03031 | RIVOTRIL | tbl 50×0.5mg | HLR | CH | ||||||
| 390.3 | N03AE01 | klonazepam (pevné lékové formy nad 0,5 mg v jedné tabletě) | p.o. | 8 | MG | 13,00 | ||||
| 391 | N03AE | antiepileptika ze skupiny benzodiazepinů | parent. | O | ||||||
| 391.1 | N03AE01 | klonazepam | parent. | 8 | MG | 244,00 | O | |||
| 03636 | RIVOTRIL | inj 25×1mg/1ml+sol | HLR | CH | ||||||
| 392 | N03AF | antiepileptika ze skupiny derivátů karboxamidu | p.o. | |||||||
| 392.1 | N03AF01 | karbamazepin (pevné lékové formy) | p.o. | 1 | GM | 12,65 | ||||
| 62309 03417 | APO-CARBAMAZEPINE 200MG BISTON | tbl 100×200mg tbl 50×200mg | APT SLO | CND SK | ||||||
| 392.2 | N03AF01 | karbamazepin (retardované pevné lékové formy) | p.o. | 1 | GM | 17,60 | ||||
| 93619 75293 60165 71954 60164 60166 | TEGRETOL CR TIMONIL RETARD TIMONIL RETARD TIMONIL RETARD TIMONIL RETARD TIMONIL RETARD | tbl obd 30×400mg tbl 100×150mg tbl 100×300mg tbl 50×150mg tbl 50×300mg tbl 50×600mg | CGC DET DET DET DET DET | CH D D D D D | ||||||
| 392.3 | N03AF01 | karbamazepin (tekuté lékové formy) | p.o. | 1 | GM | 43,50 | ||||
| 12197 72993 | TEGRETOL 2% TEGRETOL 2% | sir 1×100ml 2% sir 1×250ml 2% | CGC CGC | CH CH | ||||||
| 392.4 | N03AF02 | oxcarbazepin | p.o. | 1 | GM | 11,35 | ||||
| 393 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (kyselina valproová) | p.o. | |||||||
| 393.1 | N03AG01 | valproová kyselina (pevné lékové formy, do 150 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 19,85 | ||||
| 61183 61186 | ORFIRIL 150 ORFIRIL 150 | drg 50×150mg drg 100×150mg | DET DET | D D | ||||||
| 393.2 | N03AG01 | valproová kyselina (pevné lékové formy, nad 150 mg v 1 tabletě) | p.o. | 1.5 | GM | 16,00 | |||
| 61187 61185 61184 | ORFIRIL 300 ORFIRIL 600 ORFIRIL 300 | drg 100×300mg drg 50×600mg drg 50×300mg | DET DET DET | D D D | |||||
| 393.3 | N03AG01 | valproová kyselina (retardované pevné lékové formy) | p.o. | 1.5 | GM | 27,50 | |||
| 393.4 | N03AG01 | valproová kyselina (tekuté lékové formy) | p.o. | 1.5 | GM | 27,15 | |||
| 08770 | CONVULEX | gtt 100ml 300mg/ml | GER | A | |||||
| 394 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin (ostatní) | p.o. | L/NEU,PSY | |||||
|---|---|---|---|---|---|---|---|---|---|
| 394.1 | N03AG02 | valpromid | p.o. | 1.5 | GM | 26,20 | L/PSY,NEU | ||
| 93255 | DIPROZIN 300MG | drg 100×300mg | PLI | CHO | |||||
| 394.2 | N03AG04 | vigabatrin | p.o. | 2 | GM | 141,65 | L/PSY,NEU | ||
| 80370 | SABRIL | tbl obd 100×500mg | MDD | GB | |||||
| 395 | N03AG | antiepileptika ze skupiny derivátů mastných kyselin | parent. | K | |||||
| 395.1 | N03AG01 | valproová kyselina | parent. | 1.5 | GM | 1622,20 | K | ||
| 84386 | DEPAKINE | inj sic 4×0.4gm+4ml | SWI | F | |||||
| 396 | N03AX | ostatní antiepileptika | p.o. | L/PSY,NEU | |||||
| 396.1 | N03AX03 | sultiam | p.o. | 0.4 | GM | 17,10 | L/PSY,NEU | ||
| 55852 | OSPOLOT | tbl obd 50×200mg | DET | D | |||||
| 396.2 | N03AX09 | lamotrigin (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 572,00 | L/PSY,NEU | ||
| 84511 | LAMICTAL 5MG DISPERSIBLE/CHEW. | ctb 30×5mg | BWE | GB | |||||
| 396.3 | N03AX09 | lamotrigin (nad 5 mg do 50 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 194,60 | L/PSY,NEU | ||
| 68800 68801 84512 | LAMICTAL LAMICTAL LAMICTAL 25MG DISPERSIBLE/CHEW. | tbl 30×25mg tbl 30×50mg ctb 30×25mg | BWE BWE BWE | GB GB GB | |||||
| 396.4 | N03AX10 | felbamat | p.o. | 2.4 | GM | 365,95 | L/PSY,NEU | ||
| 77003 77004 77005 | TALOXA TALOXA 400MG TALOXA 600MG | sus 230ml 120mg/ml tbl 100×400mg tbl 100×600mg | SCH SCH SCH | B B B | |||||
| 396.5 | N03AX12 | gabapentin | p.o. | 1.8 | GM | 141,40 | L/PSY,NEU | ||
| 84398 84396 84400 84399 84402 84401 | NEURONTIN 100MG NEURONTIN 100MG NEURONTIN 300MG NEURONTIN 300MG NEURONTIN 400MG NEURONTIN 400MG | cps 100×100mg cps 20×100mg cps 100×300mg cps 50×300mg cps 100×400mg cps 50×400mg | PDA PDA PDA PDA PDA PDA | D D D D D D | |||||
| 396.6 | N03AX09 | lamotrigin (nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 161,- | L/PSY,NEU | ||
| 396.7 | N03AX11 | topiramat (do 25 mg včetně v jedné tabletě) | p.o. | 0.3 | GM | 170,- | L/PSY,NEU | ||
| 396.8 | N03AX11 | topiramat (nad 25 mg v jedné tabletě) | p.o. | 0.3 | GM | 152,- | L/PSY,NEU | |||
| 397 | N04AA | antiparkinsonika ze skupiny terciárních aminů | p.o. | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 397.1 | N04AA | hydrochlorid diethazinia | p.o. | 0.25 | GM | 6,10 | ||||
| 00102 | DEPARKIN | drg 50×50mg | LEX | CZ | ||||||
| 397.2 | N04AA02 | biperiden | p.o. | 10 | MG | 12,50 | ||||
| 397.3 | N04AA03 | metixen | p.o. | 40 | MG | 18,50 | ||||
| 397.4 | N04AA04 | procyklidin | p.o. | 25 | MG | 9,00 | ||||
| 01337 | KEMADRIN | tbl 100×5mg | BWE | GB | ||||||
| 398 | N04AA | antiparkinsonika ze skupiny terciárních aminů | parent. | O | ||||||
| 398.1 | N04AA02 | biperiden | parent. | 10 | MG | 59,85 | O | |||
| 20056 | AKINETON PRO INFUS. | inj 5×1ml/5mg | KNO | D | ||||||
| 398.2 | N04AA08 | dexetimid | parent. | 0.12 | MG | 1,75 | O | |||
| 399 | N04AC | antiparkinsonika ze skupiny esterů tropinu | p.o. | |||||||
| 399.1 | N04AC01 | benzatropin | p.o. | 2 | MG | 3,25 | ||||
| 96751 | APO-BENZTROPINE 2MG | tbl 100×2mg | APT | CND | ||||||
| 400 | N04BA | antiparkinsonika ze skupiny levodopy a jejích derivátů | p.o. | |||||||
| 400.1 | N04BA01 | levodopa | p.o. | 3.5 | GM | 25,20 | ||||
| 400.2 | N04BA02 | levodopa/karbidopa (do 125 mg v 1 tabletě včetně) | p.o. | 0.6 | GM | 30,30 | ||||
| 45241 | ISICOM 100MG | tbl 100×100mg | DET | D | ||||||
| 400.3 | N04BA02 | levodopa/karbidopa (nad 125 mg v 1 tabletě) | p.o. | 0.6 | GM | 19,75 | ||||
| 45244 | ISICOM 250MG | tbl 100×250mg | DET | D | ||||||
| 400.4 | N04BA02 | levodopa/benserazid | p.o. | 0.6 | GM | 25,15 | ||||
| 12095 | MADOPAR 250 ROCHE | tbl 30×250mg | LEX | CZ | ||||||
| 400.5 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy do 0,125 GM včetně v jedné tabletě) | p.o. | 0.6 | GM | 33,50 | ||||
| 400.6 | N04BA02 | levodopa a inhibitory dekarboxylázy (retardováné lékové formy nad 0,125 GM v jedné tabletě) | p.o. | 0.6 | GM | 27,30 | ||||
| 94843 | SINEMET CR | tbl obd 100×250mg | MSD | NL | ||||||
| 401 | N04BB | antiparkinsonika ze skupiny amantadinu a jeho derivátů | p.o. | L/NEU,PSY,GER | ||||||
| 401.1 | N04BB01 | amantadin hydrochlorid | p.o. | 0.2 | GM | 5,05 | L/NEU,PSY,GER | |||
| 02871 | VIREGYT-K | cps 50×100mg | EGI | H | ||||||
| 401.2 | N04BB01 | amantadin sulfát | p.o. | 0.2 | GM | 7,50 | L/NEU,PSY,GER | |||
| 401.3 | N04BB01 | amantadin | parent. | 0,2 | GM | 4,35 | H | |||
| 402 | N04BD | antiparkinsonika ze skupiny inhibitorů MAO | p.o. | L/NEU,PSY,GER | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 402.1 | N04BD01 | selegilin | p.o. | 5.0 | MG | 6,50 | L/NEU,PSY,GER | |||
| 92500 92501 | SEPATREM 5 SEPATREM 10 | tbl 50×5mg tbl 50×10mg | LEX LEX | CZ CZ | ||||||
| 402.2 | N04BX01 | tolkapon, do 0,1 GM včetně v jedné tabletě | p.o. | 0,3 | GM | 160,20 | X | |||
| 402.3 | N04BC02 | pergolidi mesilas (do 0,05 mg včetně v jedné tabletě) | p.o. | 3 | MG | 181,- | X | |||
| 402.4 | N04BC03 | dihydroergokriptin | p.o. | 10 | MG | 20,- | X | |||
| 402.5 | N04BC05 | pramipexol | p.o. | 1,5 | MG | 80,- | X | |||
| 402.6 | N04BC02 | pergolidi mesilas (nad 0,05 mg do 0,25 mg včetně v jedné tabletě) | p.o. | 3 | MG | 149,- | X | |||
| 402.7 | N04BC02 | pergolidi mesilas (nad 0,25 mg v jedné tabletě) | p.o. | 3 | MG | 136,- | X | |||
| 403 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | p.o. | |||||||
| 403.1 | N05AA01 | chlorpromazin (pevné lékové formy do 50 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 10,80 | ||||
| 02114 | PLEGOMAZIN | drg 50×25mg | EGI | H | ||||||
| 403.2 | N05AA01 | chlorpromazin (pevné lékové formy nad 50 mg v jedné tabletě) | p.o. | 0.3 | GM | 5,80 | ||||
| 62313 | PLEGOMAZIN | drg 30×100mg | EGI | H | ||||||
| 403.3 | N05AA01 | chlorpromazin (tekuté lékové formy) | p.o. | 0.3 | GM | 64,20 | ||||
| 403.4 | N05AA02 | levomepromazin | p.o. | 0.3 | GM | 15,00 | ||||
| 02429 | TISERCIN | tbl obd 50×25mg | EGI | H | ||||||
| 403.5 | N05AA03 | promazin | p.o. | 0.3 | GM | 13,80 | ||||
| 404 | N05AA | neuroleptika ze skupiny dimethylaminopropyl fenothiazinů | parent. | O | ||||||
| 404.1 | N05AA01 | chlorpromazin | parent. | 0.1 | GM | 25,95 | O | |||
| 00560 00561 | PLEGOMAZIN PLEGOMAZIN | inj 10×5ml/25mg inj 10x×2ml/50mg | EGI EGI | H H | ||||||
| 404.2 | N05AA02 | levomepromazin | parent. | 0.1 | GM | 31,60 | O | |||
| 01845 | TISERCIN | inj 10×1ml/25mg | EGI | H | ||||||
| 405 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | p.o. | |||||||
| 405.1 | N05AB03 | perfenazin | p.o. | 30 | MG | 1,80 | ||||
| 00262 | PERFENAZIN LECIVA | tbl obd 50×8mg | LEX | CZ | ||||||
| 405.2 | N05AB04 | prochlorperazin | p.o. | 0.1 | GM | 12,70 | ||||
| 00274 | PROCHLORPERAZIN LECIVA | tbl 20×10mg | LEX | CZ | ||||||
| 405.3 | N05AB06 | trifluoperazin | p.o. | 20 | MG | 7,15 | ||||
| 405.4 | N05AB08 | thioproperazin | p.o. | 75 | MG | 6,85 | ||||
| 406 | N05AB | neuroleptika ze skupiny piperazinových derivátů fenothiazinu | parent. | O | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 406.1 | N05AB02 | flufenazin | parent. | 1 | MG | 4,00 | O | |||
| 03514 | MODITEN DEPOT | inj 5×1ml/25mg | BTA | SK | ||||||
| 407 | N05AC | neuroleptika ze skupiny piperidinových derivátů fenothiazinu | p.o. | L/NEU,PSY,GER | ||||||
| 407.1 | N05AC01 | periciazin (tekuté lékové formy) | p.o. | 50 | MG | 5,85 | L/NEU,PSY,GER | |||
| 01559 98066 | NEULEPTIL NEULEPTIL | gtt 1×125ml 4% gtt 1×30ml 4% | RRO RRO | F F | ||||||
| 407.2 | N05AC01 | periciazin (pevné lékové formy) | p.o. | 50 | MG | 5,85 | L/NEU,PSY,GER | |||
| 407.3 | N05AC02 | thioridazin | p.o. | 0.3 | GM | 11,15 | ||||
| 00324 00325 | THIORIDAZIN 25 LECIVA THIORIDAZIN 100 LECIVA | drg 50×25mg drg 20×100mg | LEX LEX | CZ CZ | ||||||
| 408 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | p.o. | |||||||
| 408.1 | N05AD01 | haloperidol (pevné lékové formy) | p.o. | 8 | MG | 6,20 | ||||
| 98291 67110 67111 67112 67113 | APO-HALOPERIDOL HALOPER 2MG VON CT HALOPER 5MG VON CT HALOPER 10MG VON CT HALOPER 10MG VON CT | tbl 100×1mg tbl 50×2mg tbl 50×5mg tbl 20×10mg tbl 100×10mg | APT CTA CTA CTA CTA | CND D D D D | ||||||
| 408.2 | N05AD01 | haloperidol (tekuté lékové formy) | p.o. | 8 | MG | 10,35 | ||||
| 02539 | HALOPERIDOL | gtt 1×10ml/20mg | GED | H | ||||||
| 408.3 | N05AD02 | trifluperidol (tekuté lékové formy) | p.o. | 2 | MG | 7,90 | ||||
| 408.4 | N05AD02 | trifluperidol (pevné lékové formy) | p.o. | 2 | MG | 4,00 | ||||
| 408.5 | N05AD03 | melperon | p.o. | 0.3 | GM | 28,35 | ||||
| 409 | N05AD | neuroleptika ze skupiny derivátů butyrofenonu | parent. | O | ||||||
| 409.1 | N05AD01 | haloperidol (depotní lékové formy) | parent. | 3.3 | MG | 8,45 | O | |||
| 87645 87644 87643 | HALDOL DECANOAS HALDOL DECANOAS HALDOL DECANOAS | inj 1×1ml/100mg inj 1×3ml/150mg inj 5×1ml/50mg | JAN JAN JAN | B B B | ||||||
| 409.2 | N05AD01 | haloperidol | parent. | 8 | MG | 17,10 | O | |||
| 02538 | HALOPERIDOL | inj 5×1ml/5mg | GED | H | ||||||
| 409.3 | N05AD02 | trifluperidol | parent. | 2 | MG | 5,65 | O | |||
| 409.4 | N05AD03 | melperon | parent. | 0.3 | GM | 52,00 | O | |||
| 409.5 | N05AD08 | droperidol | parent. | 25 | MG | 52,00 | O | |||
| 01443 85551 | DEHYDROBENZPERIDOL DEHYDROBENZPERIDOL | inj 50×10ml/25mg inj 5×2ml/5mg | JAN JAN | B B | ||||||
| 410 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | p.o. | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 410.1 | N05AF | oxyprotepin | p.o. | 20 | MG | 18,70 | |||
| 87611 | MECLOPIN | tbl 50×5mg | LEX | CZ | |||||
| 410.2 | N05AF01 | flupentixol | p.o. | 6 | MG | 17,90 | |||
| 410.3 | N05AF03 | chlorprothixen (do 5 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 27,00 | |||
| 00082 | MINITHIXEN | drg 50×5mg | LEX | CZ | |||||
| 410.4 | N05AF03 | chlorprothixen (nad 15 mg v jedné tabletě) | p.o. | 0.3 | GM | 8,00 | |||
| 75428 | CHLORPROTHIXEN 50 LECIVA | tbl obd 30×50mg | LEX | CZ | |||||
| 410.5 | N05AF03 | chlorprothixen (od 5 do 15 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 13,00 | |||
| 75433 | CHLORPROTHIXEN 15 LECIVA | tbl obd 30×15mg | LEX | CZ | |||||
| 410.6 | N05AF05 | zuklopenthixol | p.o. | 30 | MG | 14,15 | |||
| 411 | N05AF | neuroleptika ze skupiny derivátů thioxanthenu | parent. | O | |||||
| 411.1 | N05AF | oxyprotepin | parent. | 1 | MG | 2,50 | O | ||
| 88379 | MECLOPIN | inj 5×1ml/25mg | SPX | CZ | |||||
| 411.2 | N05AF01 | flupentixol | parent. | 4 | MG | 16,55 | O | ||
| 411.3 | N05AF03 | chlorprothixen | parent. | 50 | MG | 3,10 | O | ||
| 411.4 | N05AF05 | zuklopenthixol | parent. | 30 | MG | 102,00 | O | ||
| 411.5 | N05AF05 | zuklopenthixol (depotní formy) | parent. | 15 | MG | 12,85 | O | ||
| 412 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | p.o. | ||||||
| 412.1 | N05AG02 | pimozid | p.o. | 4 | MG | 11,05 | |||
| 98120 02757 | ORAP ORAP FORTE | tbl 75×1mg tbl 20×4mg | JAN JAN | B B | |||||
| 412.2 | N05AG03 | penfluridol | p.o. | 6 | MG | 6,25 | |||
| 09684 | SEMAP | tbl 12×20mg | JAN | B | |||||
| 413 | N05AG | neuroleptika ze skupiny difenylbutylpiperidinových derivátů | parent. | O | |||||
| 413.1 | N05AG01 | fluspirilen | parent. | 0.7 | MG | 13,00 | O | ||
| 09164 98114 | IMAP IMAP | inj 1×6ml/12mg inj 3×1ml/2mg | JAN JAN | B B | |||||
| 414 | N05AH | neuroleptika ze skupiny dibenzodiazepinů a jejich derivátů | p.o. | L/PSY | |||||
| 414.1 | N05AH01 | loxapin | p.o. | 0.1 | GM | 53,40 | L/PSY | ||
| 414.2 | N05AH02 | klozapin (do 25 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 76,75 | L/PSY,NEU | ||
| 03617 | LEPONEX | tbl 50×25mg | SAN | CH | |||||